4/2018 |
Convertible Note |
2 |
$11.5M |
Shibuya Kogyo
Shinsei Corporate Investment
Shibuya Kogyo
Shinsei Corporate Investment
|
12/2019 |
Series D |
2 |
$8.4M |
Pegasus Tech Ventures
Sony Innovation Fund
Pegasus Tech Ventures
Sony Innovation Fund
|
10/2016 |
Series C |
7 |
$10.9M |
Boehringer Ingelheim Venture Fund
Fund+
Mitsubishi UFJ Capital
Mitsui Global Investment
S.R.I.W.
SMS Investments
Vesalius Biocapital Partners
Boehringer Ingelheim Venture Fund
Fund+
Mitsubishi UFJ Capital
Mitsui Global Investment
S.R.I.W.
SMS Investments
Vesalius Biocapital Partners
|
3/2012 |
Series B |
|
$0 |
Shire
Mitsui Global Investment
Boehringer Ingelheim Venture Fund
Shire
Mitsui Global Investment
Boehringer Ingelheim Venture Fund
|
11/2014 |
Series C |
|
$0 |
Boehringer Ingelheim
Shire
SFPI-FPIM
Boehringer Ingelheim
Shire
SFPI-FPIM
|
6/2019 |
Series D |
2 |
$48.1M |
ITOCHU Technology Ventures
Sansei Capital Investment
ITOCHU Technology Ventures
Sansei Capital Investment
|
2/2010 |
Series A |
4 |
$7.3M |
Vesalius Biocapital Partners
S.R.I.W.
Limburgse Reconversie Maatschappij
EQT life science
|
11/2014 |
Series C |
|
$31.4M |
Vesalius Biocapital
Boehringer Ingelheim Venture Fund
Shire
Mitsui Global Investment
SFPI-FPIM
SMS Investments
|
5/2019 |
Series D |
|
$44.4M |
Itochu Corp
Shinsei Capital Partners
Medipal Holdings Corp
Mirae Asset Capital
Korea Investment Partners
Mitsui & Co. Global Investment Ltd
|
10/2016 |
Series C |
|
$11M |
Vesalius Biocapital
SRIW
Fund+
Boehringer Ingelheim Venture Fund
|
4/2018 |
Debt |
|
$11.4M |
|
12/2019 |
Series D |
|
$8.3M |
Sony Innovation Fund
Pegasus Tech Ventures
Medipal Holdings Corporation
|
12/2019 |
Series D |
2 |
$8.4M |
Pegasus Tech Ventures
Sony Innovation Fund
Pegasus Tech Ventures
Sony Innovation Fund
|
4/2018 |
Convertible Note |
2 |
$11.5M |
Shibuya Kogyo
Shinsei Corporate Investment
Shibuya Kogyo
Shinsei Corporate Investment
|
10/2016 |
Series C |
7 |
$10.9M |
Boehringer Ingelheim Venture Fund
Fund+
Mitsubishi UFJ Capital
Mitsui Global Investment
S.R.I.W.
SMS Investments
Vesalius Biocapital Partners
Boehringer Ingelheim Venture Fund
Fund+
Mitsubishi UFJ Capital
Mitsui Global Investment
S.R.I.W.
SMS Investments
Vesalius Biocapital Partners
|
11/2014 |
Series C |
3 |
$31.6M |
|
3/2012 |
Series B |
3 |
$31.4M |
|